炼化地球的遗产:通过线粒体抗炎和持续的肠道输送,为IBD治疗疗效的比斯工程化米纳米粒子
Ganglin Wang1, Ziwei Wang1, Lin Liu1
1Key Laboratory of Laboratory Medicine, Ministry of Education of China, Zhejiang Provincial Key Laboratory of Medical Genetics, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, 325035, China.
BiHANs是一种新和酸纳米粒子,通过减少炎症和改善肠道健康,有效治疗炎症性肠病 (IBD). 这种治疗药物还提供CT成像功能用于诊断.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术 纳米技术
- 胃肠病学 胃肠病学
背景情况:
- 酸 (HA) 是一种天然化合物,具有抗炎和止痛特性,但缺乏明确的机制和输送方法.
- 炎症性肠病 (IBD) 需要新的治疗策略来进行有效的治疗和诊断.
研究的目的:
- 开发和评估BiHANs,一种新型的木-酸纳米粒子,作为IBD的向治疗和诊断剂.
- 在IBD的小鼠模型中研究BiHANs的抗炎机制和疗效.
主要方法:
- 合成和BiHANs纳米粒子的表征.
- 在体外评估生物相容性和抗炎作用.
- 在DSS诱导的IBD小鼠中口服BiHANs.
- 使用CT成像,组织学分析和肠道微生物群概况的治疗疗效的评估.
- 研究分子机制,包括NF-κB信号传递和线粒体功能.
主要成果:
- 在实验室中,BiHANs表现出优异的生物相容性和强大的抗炎作用.
- 口服BiHANs在IBD小鼠的炎症性结肠部位积累,延长了肠道保留时间.
- 双HANs通过抑制炎症,调节肠道微生物群,并抑制NF-κB驱动的细胞因子产生,显著缓解了急性和慢性肠道损伤.
- 双HANs维持了线粒体平衡,施加了抗氧化作用,并通过CT成像显示了作为治疗剂的潜力.
结论:
- 双HANs代表了针对性IBD治疗的有前途的纳米粒子平台,将显著的抗炎疗效与诊断成像能力相结合.
- 这项研究强调了BiHANs在调节肠道微生物群,向巨细胞线粒体和维持线粒体平衡的潜力,用于IBD治疗.
更多相关视频
06:04Ex Vivo Intestinal Sacs to Assess Mucosal Permeability in Models of Gastrointestinal Disease
Published on: February 9, 2016
09:01Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
